A cholinergic analogue with glandular secretion stimulatory activity. Cevimeline binds to and activates muscarinic receptors, thereby increasing the secretions in exocrine salivary and sweat glands. This cholinergic agonist also increases the tone of smooth muscle in the gastrointestinal and urinary tracts. Cevimeline is being studied as a treatment for dry mouth caused by radiation therapy to the head and neck.

A substance that increases production of saliva and tears. It is being studied as a treatment for dry mouth caused by radiation therapy to the head and neck. It belongs to the family of drugs called cholinergic enhancers.